[
    [
        {
            "time": "",
            "original_text": "智飞生物：取得重组新冠疫苗Ⅲ期临床试验关键性数据",
            "features": {
                "keywords": [
                    "智飞生物",
                    "重组新冠疫苗",
                    "Ⅲ期临床试验",
                    "关键性数据"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "智飞生物：取得重组新冠疫苗Ⅲ期临床试验关键性数据",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "智飞生物接受140家机构调研！短期主力资金净流入，市场资金或早已察觉",
            "features": {
                "keywords": [
                    "智飞生物",
                    "机构调研",
                    "主力资金净流入",
                    "市场资金"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物接受140家机构调研！短期主力资金净流入，市场资金或早已察觉",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "智飞生物：公司于去年参与深圳深信生物科技有限公司融资，该公司是一家主要从事mRNA技术研发和药品研究开发的生物企业",
            "features": {
                "keywords": [
                    "智飞生物",
                    "深圳深信生物",
                    "mRNA技术",
                    "融资"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "mRNA技术"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "智飞生物：公司于去年参与深圳深信生物科技有限公司融资，该公司是一家主要从事mRNA技术研发和药品研究开发的生物企业",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "智飞生物：目前己取得重组新冠疫苗Ⅲ期临床试验关键性数据，结果显示出具有很好的安全性和防病效果",
            "features": {
                "keywords": [
                    "智飞生物",
                    "重组新冠疫苗",
                    "Ⅲ期临床试验",
                    "安全性",
                    "防病效果"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "智飞生物：目前己取得重组新冠疫苗Ⅲ期临床试验关键性数据，结果显示出具有很好的安全性和防病效果",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]